Study Finds No Increase in Long-Term Renal Survival in Patients with IgA Nephropathy
The 3-year and 5-year renal survival rates did not exhibit significant changes, but IgAN's 10-year renal survival has shown gradual decreases since the 1990s.
Stay updated with breaking news from Akram Huseyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The 3-year and 5-year renal survival rates did not exhibit significant changes, but IgAN's 10-year renal survival has shown gradual decreases since the 1990s.
Virios Therapeutics, Inc. (NASDAQ:VIRI) Q2 2023 Earnings Call Transcript August 10, 2023 Virios Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. Operator: Good day, and welcome to the Virios Therapeutics, Inc. Q2 2023 Earnings Update. At this time, all participants have been placed in a listen-only mode. Please be […]
Operator: Good morning, and welcome to the Wave Life Sciences Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Operator: Good day ladies and gentlemen and welcome to CymaBay's Fourth Quarter and Full-Year 2022 Financial Results and Business Update Conference Call.
FRESNO STATE -- Sydney Fox has made a competition out of taking her education as far as she can. An avid runner since childhood, her analysis concludes that...